STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with STAAR Management at the upcoming Stephens Annual Investment Conference, which will be held in Nashville, TN.

Event: Stephens Annual Investment Conference (NASH2024)
Management Attendee: Patrick F. Williams, Chief Financial Officer
Date: Wednesday, November 20, 2024
Time: 11:00 a.m. ET / 8:00 a.m. PT
Location: Live Webcast

The live webcast link includes an option to pre-register. An online replay of the webcast will also be available on STAAR’s investor website at https://investors.staar.com/.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241113681040/en/

Investors & Media
Brian Moore
Vice President, Investor Relations and Corporate Development
(626) 303-7902, Ext. 3023
[email protected]

Connie Johnson
Director, Investor Relations and HPMS
(626) 303-7902, Ext. 2207
[email protected]

Source: STAAR Surgical Company

You May Also Be Interested In

• South African Food Science Leader Gunnar Sigge Begins Term as President of the Institute of Food Technologists
• Solana Price Prediction Targets $150 but Early Pepeto Wallets Could See 150x First
• CrowdStrike Announces 2026 Customer and Partner Award Winners: The Leaders Securing the Front Lines of AI